What is Gorham Stout disease

TL;DR: Gorham-Stout disease, also known as "vanishing bone disease," is a rare skeletal disorder characterized by the uncontrolled proliferation of lymphatic vessels, which leads to the progressive resorption and destruction of bone tissue. While it can affect any part of the skeleton, it most commonly involves the skull, spine, ribs, and pelvis, and there is currently no cure, though management focuses on stabilizing the affected areas.

What exactly is Gorham-Stout disease?

Gorham-Stout disease is a rare condition where the body’s lymphatic system—which normally helps drain fluid and support the immune system—begins to grow abnormally within the bone. This excessive growth of lymphatic vessels (lymphangiomatosis) causes the bone to break down and be replaced by fibrous tissue and fluid-filled channels. Because the bone is essentially "eaten away," the condition is often referred to as vanishing bone disease. At DiseaseMaps.org, we have seen 10 members join our community to share their experiences, highlighting the isolation often felt by those navigating this rare diagnosis.

How does Gorham-Stout disease affect the body?

The impact of Gorham-Stout disease varies significantly depending on the location of the bone resorption. When the disease affects the ribs or thoracic spine, it can lead to serious complications such as chylothorax, a condition where lymphatic fluid leaks into the chest cavity, causing breathing difficulties. Common clinical features include:

• Progressive bone pain and localized swelling.


• Pathological fractures (bone breaks occurring without significant trauma).


• Deformity or shortening of the affected limb or region.


• Neurological symptoms if the spine or base of the skull is involved.


• Functional impairment of the joints near the affected bone.

Who is typically affected by Gorham-Stout disease?

Gorham-Stout disease is exceptionally rare, with fewer than 300 cases documented in medical literature worldwide. It does not show a clear hereditary pattern, and it is not considered a genetic condition passed from parents to children. It can affect individuals of any age, though it is most frequently diagnosed in children and young adults under the age of 40. There is no significant geographic, ethnic, or gender predilection, meaning it affects individuals from all walks of life equally.

What causes this bone destruction?

The underlying mechanism of Gorham-Stout disease is rooted in an abnormal activation of the lymphatic system within the bone microenvironment. Researchers believe that an increase in specific proteins, such as vascular endothelial growth factor (VEGF), triggers the proliferation of lymphatic endothelial cells. This "overgrowth" disrupts the normal balance of bone-forming cells (osteoblasts) and bone-resorbing cells (osteoclasts), leading to the aggressive loss of bone mass that defines Gorham-Stout disease.

How is Gorham-Stout disease different from other conditions?

Distinguishing Gorham-Stout disease from other conditions is critical, as it is often misdiagnosed as cancer or bone infection. Unlike metastatic bone cancer, Gorham-Stout disease does not involve malignant cells. Unlike osteoporosis, which is a systemic thinning of the bones, this disease is characterized by localized, aggressive, and progressive destruction that can cross joint spaces, which is a hallmark feature that helps clinicians differentiate it from other osteolytic disorders.

Next steps

• Consult an orthopedic oncologist or a specialist in rare skeletal disorders to establish a multidisciplinary care team.


• Request imaging studies (MRI and CT scans) to monitor the extent of bone resorption and ensure no involvement of the chest cavity.


• Join a patient support group or the Gorham-Stout community at DiseaseMaps.org to connect with others who understand the diagnostic journey.


• Discuss potential therapeutic options, such as bisphosphonates, radiation therapy, or anti-angiogenic medications, with your specialist.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from your healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Gorham-Stout disease overview.


• Orphanet: Rare disease database entry for Gorham-Stout disease (ORPHA:374).


• OMIM (Online Mendelian Inheritance in Man): Clinical summary of vanishing bone disease.


• The Gorham-Stout Disease Alliance: Patient advocacy and research resources.